Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03075988
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
IH4 | N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2- PHENYLETHYL) | A | 2BJU | 0.72 | |
HAN | 2-AMINO-5,6-DIMETHYL-BENZIMIDAZOLE- 1-PENTANOIC ACID | B,D,E,H | 1Y18 | 0.76 | |
HAN | 2-AMINO-5,6-DIMETHYL-BENZIMIDAZOLE- 1-PENTANOIC ACID | A,D,E,F,H | 1Y0L | 0.76 | |
C24 | 3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-3-METHYL-3H-BENZOIMIDAZOLE- 5-CARBONYL}-PYRIDIN-2-YL-AMINO)- PROPIONIC ACID ETHYL ESTER | B,C | 1KTS | 0.74 | |
CMM | 2-[2-(1-CARBAMIMIDOYL-PIPERIDIN- 3-YL)-ACETYLAMINO]-3-{4-[2-(3-OXALYL- 1H-INDOL-7-YL)ETHYL]-PHENYL}-PROPIONIC ACID METHYL ESTER | A,B | 1M49 | 0.73 | |
MS1 | A,B | 1OZ0 | 0.71 | ||
778 | 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN- 1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE | B,C,D,F,G,H, I,J,K,L | 1S64 | 0.7 | |
778 | 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN- 1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE | B | 1S63 | 0.7 | |
146 | [4R-(4ALPHA,5ALPHA,6ALPHA,7ALPHA)]- 3,3'-{{TETRAHYDRO-5,6-DIHYDROXY- 2-OXO-4,7-BIS(PHENYLMETHYL)-1H- 1,3-DIAZEPINE-1,3(2H)-DIYL]BIS(METHYLENE)]BIS[N- 1H-BENZIMIDAZOL-2-YLBENZAMIDE] | B | 1QBT | 0.71 | |
146 | [4R-(4ALPHA,5ALPHA,6ALPHA,7ALPHA)]- 3,3'-{{TETRAHYDRO-5,6-DIHYDROXY- 2-OXO-4,7-BIS(PHENYLMETHYL)-1H- 1,3-DIAZEPINE-1,3(2H)-DIYL]BIS(METHYLENE)]BIS[N- 1H-BENZIMIDAZOL-2-YLBENZAMIDE] | B | 1BWB | 0.71 | |
057 | N-(2-hydroxy-1,1-dimethylethyl)- 1-methyl-3-(1H-pyrrolo[2,3-b]pyridin- 2-yl)-1H-indole-5-carboxamide | A,B | 3FQH | 0.72 | |
1N8 | N-{2-[(N,N-DIETHYLGLYCYL)AMINO]- 5-(TRIFLUOROMETHYL)PHENYL}-4-METHYL- 3-[2-(METHYLAMINO)QUINAZOLIN-6- YL]BENZAMIDE | A,B | 2OG8 | 0.71 | |
FR6 | 1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 2E1W | 0.72 | |
L34 | 4-(7-AMINO-9-HYDROXY-1-OXO-3,3A,4,5- TETRAHYDRO-2,5,6,8,9B-PENTAAZA- CYCLOPENTA[A]NAPHTHALEN-2-YL)-PHENYLCARBONYL- GLUTAMIC ACID | A,B | 1DIB | 0.72 | |
AM6 | 2-methyl-N-{4-methyl-3-[(2-{[4- (4-methylpiperazin-1-yl)phenyl]amino}pyrimidin- 5-yl)carbamoyl]phenyl}-3-(trifluoromethyl)benzamide | A | 3BYU | 0.71 | |
FTI | 1-{2-[3-(4-CYANO-BENZYL)-3H-IMIDAZOL- 4-YL]-ACETYL}-5-NAPHTHALEN-1-YL- 1,2,3,6-TETRAHYDRO-PYRIDINE-4-CARBONITRILE | B | 1N9A | 0.74 | |
FTL | 4-[(3-CYANO-BENZYL)-(3-METHYL-3H- IMIDAZOL-4-YLMETHYL)-AMINO]-2-NAPHTHALEN- 1-YL-BENZONITRILE | B | 1NL4 | 0.7 | |
OQB | 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-METHYL}-PYRIDINE- 3-CARBONYL)-AMINO]-BUTYRIC ACID | A | 1RWW | 0.7 | |
FR3 | 1-((1R)-1-(HYDROXYMETHYL)-3-(1- NAPHTHYL)PROPYL)-1H-IMIDAZOLE-4- CARBOXAMIDE | A | 1NDY | 0.72 | |
T42 | MORPHOLINO-DIPHENYLALANINE-METHOXYPROPYLBORONIC ACID | H,I | 1AI8 | 0.71 | |
FE1 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D | 2QHX | 0.72 | |
TCR | CYCLOMETHYLTRYPTOPHAN | A | 3AIG | 0.7 | |
FR4 | 1-((1R)-1-(HYDROXYMETHYL)-3-{6- [(3-PHENYLPROPANOYL)AMINO]-1H-INDOL- 1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1UML | 0.74 | |
KAW | N-{(5S)-4,4-dihydroxy-6-phenyl- 5-[(phenylcarbonyl)amino]hexanoyl}- L-tryptophan | A | 3BKL | 0.71 | |
FXG | N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide | A | 3DAJ | 0.71 | |
JAN | 6-[(S)-AMINO(4-CHLOROPHENYL)(1- METHYL-1H-IMIDAZOL-5-YL)METHYL]- 4-(3-CHLOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE | B | 1X81 | 0.71 | |
JAN | 6-[(S)-AMINO(4-CHLOROPHENYL)(1- METHYL-1H-IMIDAZOL-5-YL)METHYL]- 4-(3-CHLOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE | B | 1SA4 | 0.71 | |
RSS | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA- 12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)- HEXANOIC ACID | A,B | 1MMP | 0.73 | |
406 | N-[3-(4,5'-BIPYRIMIDIN-2-YLAMINO)- 4-METHYLPHENYL]-4-{[(3S)-3-(DIMETHYLAMINO)PYRROLIDIN- 1-YL]METHYL}-3-(TRIFLUOROMETHYL)BENZAMIDE | A,B | 2E2B | 0.71 | |
IDN | (E)-N-METHYL-N-(1-METHYL-1H-INDOL- 3-YLMETHYL)-3-(7-OXO-5,6,7,8-TETRAHYDRO- [1,8]NAPHTHYRIDIN-3-YL)-ACRYLAMIDE | A,B | 1MFP | 0.7 | |
GRD | benzyl (S)-1-((2S,3S)-1-(3-(6-amino- 9H-purin-9-yl)propylamino)-2-hydroxy- 1-oxopentan-3-ylamino)-4-methyl- 1-oxopentan-2-ylcarbamate | A | 2R9C | 0.7 | |
4QB | 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-HEXANOYLAMINO}-4- OXO-BUTYRIC ACID | A | 1RWN | 0.71 | |
POO | 3-CYCLOHEXYL-1-(2-{METHYL[(1-METHYLPIPERIDIN- 3-YL)METHYL]AMINO}-2-OXOETHYL)- 2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID | A | 2BRL | 0.74 | |
FR9 | 1-[(1R)-3-(6-{[(BENZYLAMINO)CARBONYL]AMINO}- 1H-INDOL-1-YL)-1-(HYDROXYMETHYL)PROPYL]- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1O5R | 0.73 | |
CMF | 3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL- 2-OXOETHYL)-2-PHENYL-1H-INDOLE- 6-CARBOXYLIC ACID | A | 2BRK | 0.71 | |
FR5 | 1-((1R)-1-(HYDROXYMETHYL)-3-(6- ((3-(1-METHYL-1H-BENZIMIDAZOL-2- YL)PROPANOYL)AMINO)-1H-INDOL-1- YL)PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1NDZ | 0.72 | |
ED1 | B | 3E34 | 0.79 | ||
XX5 | (S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO- BENZYL)-3H-IMIDAZOL-4-YL]-ETHYLAMINO}- 4-METHYL-PENTANOIC ACID | A | 1R4L | 0.74 | |
FTB | N-{4-[1-(2-FLUOROBENZYL)-3-BUTYL- 2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H- PURIN-8-YLMETHYL]-PHENYL}-ACETAMIDE | A | 1NHX | 0.71 | |
3BI | (2S)-2-{[(R)-[(3R)-3-carboxy-3- {[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]amino}propyl](hydroxy)phosphoryl]methyl}pentanedioic acid | A | 3BI1 | 0.71 | |
CCK | [1-(6-{6-[(1-methylethyl)amino]- 1H-indazol-1-yl}pyrazin-2-yl)-1H- pyrrol-3-yl]acetic acid | X | 3E3B | 0.72 | |
CX1 | N-[(benzyloxy)carbonyl]-L-histidyl- N-methyl-L-phenylalanyl-L-tyrosine | B | 3C72 | 0.71 | |
FA9 | A | 2UXX | 0.7 | ||
FA9 | A | 2Z5U | 0.7 | ||
GPB | N-[4-[2-(2-AMINO-4-METHYL-7H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYL]GLUTAMIC ACID | A | 1E26 | 0.73 | |
6HI | (3R,5R)-7-{2-[(4-fluorobenzyl)carbamoyl]- 4-(4-fluorophenyl)-1-(1-methylethyl)- 1H-imidazol-5-yl}-3,5-dihydroxyheptanoic acid | B,C,D | 3CD0 | 0.73 | |
PB4 | N,N'-BIS(4-FLUORO-3-METHYLBENZYL)PYRIMIDINE- 4,6-DICARBOXAMIDE | A,B | 1XUD | 0.71 | |
HR1 | (3R,5R)-7-[1-(4-FLUOROPHENYL)-3- ISOPROPYL-4-OXO-5-PHENYL-4,5-DIHYDRO- 3H-PYRROLO[2,3-C]QUINOLIN-2-YL]- 3,5-DIHYDROXYHEPTANOIC ACID | A,B,C,D | 2Q6C | 0.71 | |
C1B | H | 2B7D | 0.71 | ||
BIM | BIS-(INDOLE)MALEIMIDE PYRIDINOPHANE | A,B | 2OW3 | 0.7 | |
MT1 | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM- 6-YL)METHYL](METHYL)AMINO}BENZOYL)- L-GLUTAMIC ACID | A,B | 2INQ | 0.73 | |
HBN | N-(2-NAPHTHYL)HISTIDINAMIDE | B | 1VEA | 0.73 | |
GDV | (5R,6R,7R,8S)-8-(ACETYLAMINO)-6,7- DIHYDROXY-5-(HYDROXYMETHYL)-N-PHENYL- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDINE-2-CARBOXAMIDE | A | 2J47 | 0.71 | |
MTX | METHOTREXATE | A,B | 1DRB | 0.75 | |
MTX | METHOTREXATE | A,B,C,D | 2C7V | 0.75 | |
MTX | METHOTREXATE | A | 1U70 | 0.75 | |
MTX | METHOTREXATE | A,B,C,D | 1MXF | 0.75 | |
MTX | METHOTREXATE | A | 2QK8 | 0.75 | |
MTX | METHOTREXATE | A,B | 1RB3 | 0.75 | |
MTX | METHOTREXATE | A,B | 1DHJ | 0.75 | |
MTX | METHOTREXATE | A | 3DAU | 0.75 | |
MTX | METHOTREXATE | A | 1U72 | 0.75 | |
MTX | METHOTREXATE | A,B | 2DRC | 0.75 | |
MTX | METHOTREXATE | A,B | 1D1G | 0.75 | |
MTX | METHOTREXATE | A,B | 1DDR | 0.75 | |
MTX | METHOTREXATE | A,B | 1E7W | 0.75 | |
MTX | METHOTREXATE | A | 1RX3 | 0.75 | |
MTX | METHOTREXATE | A | 3DFR | 0.75 | |
MTX | METHOTREXATE | A,B,C,D | 1P33 | 0.75 | |
MTX | METHOTREXATE | A | 3DAT | 0.75 | |
MTX | METHOTREXATE | A,B | 1DHI | 0.75 | |
MTX | METHOTREXATE | A,B | 1TDR | 0.75 | |
MTX | METHOTREXATE | A,B | 1DRA | 0.75 | |
MTX | METHOTREXATE | A | 3EIG | 0.75 | |
MTX | METHOTREXATE | A | 3CD2 | 0.75 | |
MTX | METHOTREXATE | A | 1AO8 | 0.75 | |
MTX | METHOTREXATE | A | 1DF7 | 0.75 | |
MTX | METHOTREXATE | A | 1DLS | 0.75 | |
MTX | METHOTREXATE | A | 1RG7 | 0.75 | |
MTX | METHOTREXATE | A | 1RH3 | 0.75 | |
MTX | METHOTREXATE | A,B | 4DFR | 0.75 | |
MTX | METHOTREXATE | A | 1RA3 | 0.75 | |
MTX | METHOTREXATE | A,B | 1DDS | 0.75 | |
MTX | METHOTREXATE | A | 1DRE | 0.75 | |
MTX | METHOTREXATE | A,B | 1AXW | 0.75 | |
MTX | METHOTREXATE | A | 3CL9 | 0.75 | |
MTX | METHOTREXATE | A,B | 3DRC | 0.75 | |
MTX | METHOTREXATE | A,B,C,D,E | 2OIP | 0.75 | |
3MN | 3-({3-[3-(1H-IMIDAZOL-1-YL)PROPYL]- 5-METHYL-5-(1-NAPHTHYL)-2,4-DIOXOIMIDAZOLIDIN- 1-YL}METHYL)BENZONITRILE | B | 2F0Y | 0.71 | |
VGB | (5R,6R,7R,8S)-6,7-dihydroxy-5-(hydroxymethyl)- 2-(2-phenylethyl)-8-(propanoylamino)- 5,6,7,8-tetrahydro-1H-imidazo[1,2- a]pyridin-4-ium | A,B | 2WB5 | 0.72 | |
IQA | (5-OXO-5,6-DIHYDRO-INDOLO[1,2-A]QUINAZOLIN- 7-YL)-ACETIC ACID | A | 1OM1 | 0.73 | |
C19 | 3-(2-aminoquinazolin-6-yl)-1-(3,3- dimethylindolin-6-yl)-4-methylpyridin- 2(1H)-one | A,B | 3CP9 | 0.73 | |
PB3 | N,N'-BIS(3-METHYLBENZYL)PYRIMIDINE- 4,6-DICARBOXAMIDE | A,B | 1XUC | 0.72 | |
FTH | 1-[2-(4-CYANO-BENZYLAMINO)-3-(3- METHYL-3H-IMIDAZOL-4-YL)-PROPIONYL]- 5-NAPHTHALEN-1-YL-1,2,3,6-TETRAHYDRO- PYRIDINE-4-CARBONITRILE | B | 1N95 | 0.75 | |
FR8 | 1-((1R)-1-(HYDROXYMETHYL)-3-{6- [(5-PHENYLPENTANOYL)AMINO]-1H-INDOL- 1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1QXL | 0.75 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.75 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.75 | |
NIL | Nilotinib | A,B,C,D | 3CS9 | 0.71 | |
NIL | Nilotinib | A | 3GP0 | 0.71 | |
RC8 | (2R)-2-({9-(1-methylethyl)-6-[(4- pyridin-2-ylbenzyl)amino]-9H-purin- 2-yl}amino)butan-1-ol | A,C | 3DDP | 0.7 | |
IAV | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | A,B | 1K7F | 0.71 | |
PVB | PURVALANOL | A | 1CKP | 0.72 | |
PVB | PURVALANOL | A,B | 1V0P | 0.72 | |
S48 | METHYL N-{(3S)-1-[(1-METHYL-1H- IMIDAZOL-5-YL)METHYL]-6-PHENYL- 1,2,3,4-TETRAHYDROQUINOLIN-3-YL}- N-[(1-METHYL-1H-IMIDAZOL-4-YL)SULFONYL]GLYCINATE | A,B | 2IEJ | 0.73 | |
I19 | N-(4-{[(3S)-3-(dimethylamino)pyrrolidin- 1-yl]carbonyl}phenyl)-5-fluoro- 4-[2-methyl-1-(1-methylethyl)-1H- imidazol-5-yl]pyrimidin-2-amine | A | 2W17 | 0.71 | |
GSZ | N-[(5R,6R,7R,8S)-6,7-DIHYDROXY- 5-(HYDROXYMETHYL)-2-(2-PHENYLETHYL)- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDIN-8-YL]-2-METHYLPROPANAMIDE | A,B | 2J62 | 0.72 | |
DVP | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D,E,F, G,H | 3H4V | 0.71 | |
FOL | FOLIC ACID | A | 1PJ6 | 0.74 | |
FOL | FOLIC ACID | A,B | 1RD7 | 0.74 | |
FOL | FOLIC ACID | A,B | 1DHF | 0.74 | |
FOL | FOLIC ACID | A,B,C,D,E | 1QZF | 0.74 | |
FOL | FOLIC ACID | A | 4CD2 | 0.74 | |
FOL | FOLIC ACID | A | 1RX7 | 0.74 | |
FOL | FOLIC ACID | A | 1RX2 | 0.74 | |
FOL | FOLIC ACID | A | 1RX8 | 0.74 | |
FOL | FOLIC ACID | A | 1RA2 | 0.74 | |
FOL | FOLIC ACID | A,B | 1RE7 | 0.74 | |
FOL | FOLIC ACID | A | 7DFR | 0.74 | |
FOL | FOLIC ACID | A | 1VIF | 0.74 | |
FOL | FOLIC ACID | A,B | 1RB2 | 0.74 | |
FOL | FOLIC ACID | A | 1CD2 | 0.74 | |
FOL | FOLIC ACID | A | 2CD2 | 0.74 | |
FOL | FOLIC ACID | A,B | 1DYI | 0.74 | |
FOL | FOLIC ACID | A | 1DRF | 0.74 | |
FOL | FOLIC ACID | A,B,C,D | 3BMC | 0.74 | |
FOL | FOLIC ACID | A,B | 2D0K | 0.74 | |
FOL | FOLIC ACID | A | 1RA8 | 0.74 | |
WSA | 5'-O-[(L-TRYPTOPHYLAMINO)SULFONYL]ADENOSINE | A,B,C,D | 2YY5 | 0.7 | |
G37 | 2-(BENZYLCARBAMOYL-PHENYLACETYLAMINO- METHYL)-5,5-DIMETHYL-THIAZOLIDINE- 4-CARBOXYLIC ACID 3-[(1H-BENZIMIDAZOL- 2-YLMETHYLCARBAMOYL)-1-BENZYL-2- HYDROXYPROPYL]-AMIDE | A | 1HTG | 0.72 | |
KSL | N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5- a]pyrazin-8-amine | A | 2ZYB | 0.74 | |
P40 | N-cyclopropyl-4-methyl-3-{2-[(2- morpholin-4-ylethyl)amino]quinazolin- 6-yl}benzamide | A | 3DT1 | 0.7 | |
TSX | N-[4-(1-ALLYL-3-BUTYL-2,6-DIOXO- 2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL)- PHENYL]-ACETAMIDE | A | 1M51 | 0.7 | |
5HI | (3R,5R)-7-[2-(4-fluorophenyl)-4- {[(1S)-2-hydroxy-1-phenylethyl]carbamoyl}- 5-(1-methylethyl)-1H-imidazol-1- yl]-3,5-dihydroxyheptanoic acid | A,B,C,D | 3CCZ | 0.71 |